Limits...
CaCO₃/CaIP₆ composite nanoparticles effectively deliver AKT1 small interfering RNA to inhibit human breast cancer growth.

Zhou H, Wei J, Dai Q, Wang L, Luo J, Cheang T, Wang S - Int J Nanomedicine (2015)

Bottom Line: ACC/CaIP6 nanoparticles effectively transfected cells with little or no toxicity.AKT1 knockdown by ACC/CaIP6/siAKT1 inhibited cell cycle progression and promoted apoptosis of MCF-7 cells.ACC/CaIP6 nanoparticles are a safe and efficient method of delivering siRNA for gene therapy in breast cancer.

View Article: PubMed Central - PubMed

Affiliation: Department of Neurological Intensive Care Unit, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.

ABSTRACT

Background: Small interfering RNA (siRNA)-mediated gene therapy is a promising strategy to temporarily inhibit the expression of genes involved in development of breast cancer. The lack of a safe and efficient gene delivery system has become a major hurdle for siRNA-mediated gene therapy in breast cancer. Our previous studies have demonstrated that inorganic amorphous calcium carbonate (ACC) hybrid nanospheres functionalized with CaIP6 (ACC/CaIP6) nanoparticles are an efficient nucleic acid delivery tool. The present study aimed to evaluate the safety and efficiency of ACC/CaIP6 in delivering siRNA targeting AKT1 (siAKT1) for the treatment of breast cancer.

Methods: The cytotoxicity of the ACC/CaIP6 nanoparticles was evaluated using a tetrazolium assay. The transfection efficiency and intracellular distribution of ACC/siAKT1 were analyzed by flow cytometry and confocal laser scanning microscopy, respectively. A series of in vitro and in vivo assays was performed to evaluate the effects of ACC/CaIP6/siAKT1 on growth of breast cancer cells.

Results: ACC/CaIP6 nanoparticles effectively transfected cells with little or no toxicity. AKT1 knockdown by ACC/CaIP6/siAKT1 inhibited cell cycle progression and promoted apoptosis of MCF-7 cells. Intratumoral injection of ACC/CaIP6/siAKT1 significantly suppressed the growth of breast cancer in mice.

Conclusion: ACC/CaIP6 nanoparticles are a safe and efficient method of delivering siRNA for gene therapy in breast cancer.

No MeSH data available.


Related in: MedlinePlus

Scanning electron micrograph of amorphous calcium carbonate hybrid nanospheres functionalized with a Ca(II)-inositol hexakisphosphate compound.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4494612&req=5

f1-ijn-10-4255: Scanning electron micrograph of amorphous calcium carbonate hybrid nanospheres functionalized with a Ca(II)-inositol hexakisphosphate compound.

Mentions: The detailed methods for preparing the ACC/CaIP6 nanoparticles can be found in our previous studies.11,12 The nanoparticles were characterized by scanning electron microscopy (Figure 1). Scanning electron micrographs of hybrid ACC/CaIP6 nanoparticles show spherical particles with diameters of 80–200 nm that were composed of approximately 90% ACC and 10% CaIP6. The 80–200 nm sizes and spherical characteristics provide the nanoparticles with a large surface area and a high capacity for surface DNA complexation. The cationic charge (+30.81 mV by zeta potential measurements) of these nanoparticles adsorbed easily on the negatively charged cell membrane surface and consequently afforded the nanoparticles a high likelihood for internalization.11,12


CaCO₃/CaIP₆ composite nanoparticles effectively deliver AKT1 small interfering RNA to inhibit human breast cancer growth.

Zhou H, Wei J, Dai Q, Wang L, Luo J, Cheang T, Wang S - Int J Nanomedicine (2015)

Scanning electron micrograph of amorphous calcium carbonate hybrid nanospheres functionalized with a Ca(II)-inositol hexakisphosphate compound.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4494612&req=5

f1-ijn-10-4255: Scanning electron micrograph of amorphous calcium carbonate hybrid nanospheres functionalized with a Ca(II)-inositol hexakisphosphate compound.
Mentions: The detailed methods for preparing the ACC/CaIP6 nanoparticles can be found in our previous studies.11,12 The nanoparticles were characterized by scanning electron microscopy (Figure 1). Scanning electron micrographs of hybrid ACC/CaIP6 nanoparticles show spherical particles with diameters of 80–200 nm that were composed of approximately 90% ACC and 10% CaIP6. The 80–200 nm sizes and spherical characteristics provide the nanoparticles with a large surface area and a high capacity for surface DNA complexation. The cationic charge (+30.81 mV by zeta potential measurements) of these nanoparticles adsorbed easily on the negatively charged cell membrane surface and consequently afforded the nanoparticles a high likelihood for internalization.11,12

Bottom Line: ACC/CaIP6 nanoparticles effectively transfected cells with little or no toxicity.AKT1 knockdown by ACC/CaIP6/siAKT1 inhibited cell cycle progression and promoted apoptosis of MCF-7 cells.ACC/CaIP6 nanoparticles are a safe and efficient method of delivering siRNA for gene therapy in breast cancer.

View Article: PubMed Central - PubMed

Affiliation: Department of Neurological Intensive Care Unit, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.

ABSTRACT

Background: Small interfering RNA (siRNA)-mediated gene therapy is a promising strategy to temporarily inhibit the expression of genes involved in development of breast cancer. The lack of a safe and efficient gene delivery system has become a major hurdle for siRNA-mediated gene therapy in breast cancer. Our previous studies have demonstrated that inorganic amorphous calcium carbonate (ACC) hybrid nanospheres functionalized with CaIP6 (ACC/CaIP6) nanoparticles are an efficient nucleic acid delivery tool. The present study aimed to evaluate the safety and efficiency of ACC/CaIP6 in delivering siRNA targeting AKT1 (siAKT1) for the treatment of breast cancer.

Methods: The cytotoxicity of the ACC/CaIP6 nanoparticles was evaluated using a tetrazolium assay. The transfection efficiency and intracellular distribution of ACC/siAKT1 were analyzed by flow cytometry and confocal laser scanning microscopy, respectively. A series of in vitro and in vivo assays was performed to evaluate the effects of ACC/CaIP6/siAKT1 on growth of breast cancer cells.

Results: ACC/CaIP6 nanoparticles effectively transfected cells with little or no toxicity. AKT1 knockdown by ACC/CaIP6/siAKT1 inhibited cell cycle progression and promoted apoptosis of MCF-7 cells. Intratumoral injection of ACC/CaIP6/siAKT1 significantly suppressed the growth of breast cancer in mice.

Conclusion: ACC/CaIP6 nanoparticles are a safe and efficient method of delivering siRNA for gene therapy in breast cancer.

No MeSH data available.


Related in: MedlinePlus